What are the factors that affect the bid price of drugs?

In the regional drug procurement projects, the company's most concerned results: First, whether the bid can be successful, and second, the bid price. The first issue is the question of qualification access, either winning the bid or dropping the bid. The second is measuring the quality of the winning bid. Reason is good, too high or too low is bad.

So, what are the factors that affect the price of drugs for winning bids? Judging from the tendering projects in recent years, it can be roughly summarized as four major aspects: objective factors, subjective factors, price factors and political factors. Among them, the objective factors and subjective factors constitute the economic and technical standard in the “double envelope” evaluation system, which is used as the bid evaluation index for commercial products for bidding products; in the comprehensive evaluation system, the bid price of the participating bidding products is high or low, objective or subjective. How much, directly affect the decision for the bid price. For each project, the economic and technical scores for the comprehensive evaluation system are generally between 55 and 70 (excluding the Guangdong Drug Exchange-based drug project, the sub-point is only 10 points). The following discusses one by one on objective factors, subjective factors, price factors, and environmental factors.

The first is the objective factor:

The objective factors of economic and technological standards are divided into corporate and product factors. The most important corporate factor is the size of the company and the industry rankings. In the review rules for individual projects, they also assess the industry (Hubei based medicine), records of creditworthiness, whether it is a “contract-keeping, re-credit” enterprise, and a comprehensive pilot of provincial-level government technology innovation. Enterprises, national well-known trademarks, donations, and local pharmaceutical strategic reserves are also assigned accordingly. Product factors include quality reliability, quality type of drugs, reserve conditions, drug expiration date, brand awareness, corporate reputation, and distribution rate.

Followed by subjective factors:

The subjective factor is a judging panel composed of experts in medicine and pharmacy related to medicines. According to clinical efficacy evaluation literature and clinical use, drug safety evaluation of medicines, packaging quality and convenient and practical conditions, protection of supply and accompanying services, quality inspection, Brand recognition, credibility and other aspects.

The third is the price factor:

The current bidding price limit establishment collects the winning bid prices of other provinces. The method of collection is based on the current purchase price of the province (city, district), and formulates the principle based on the lowest price in the country, the lowest price in the provinces collected, and the average price in the provinces collected. Calculation. Therefore, to a large extent, the low price of the collected provinces directly or indirectly influences the establishment of the price limit.

Fourth, environmental factors:

The state has always rigorously controlled the price of drugs. According to a university professor of drug policy research, in recent years, the National Development and Reform Commission has conducted a total of 32 price cuts; under a large price reduction environment, it has seriously affected the price of centralized drug procurement.

Since 2015, the wave of price cuts has continued to hit, and the leaders of the National Health and Planning Commission have repeatedly stated on various occasions that it is necessary to lower prices for drugs. From the perspective of recent tendering projects, the second batch of Zhejiang provinces will impose a price reduction of 10% and negotiate twice. , Forced to cut prices by 25%, April 23, rumored that the documents, some companies have failed to comply with the requirements of all products for the company's permanent use, this information came out, caused a lot of sensation in the industry.

Of course, there are still many prices that affect the centralized procurement of drugs, such as in-hospital procurement and other sales prices in the market. The above analysis is based on the four aspects that are more common.